參考文獻(xiàn)/References:
[1] SEHAT K R,EVANS R,NEWMAN J H.How much blood is really lost in total knee arthroplasty?Correct blood loss management should take hidden loss into account[J].Knee,2000,7(3):151-155.
[2] GROSS J B.Estimating allowable blood loss:corrected for dilution[J].Anesthesiology,1983,58(3):277-280.
[3] NADLER S B,HIDALGO J H,BLOCH T.Prediction of blood volume in normal human adults[J].Surgery,1962,51(2):224-232.
[4] JU H,HART R A.Hidden blood loss in anterior lumbar interbody fusion(ALIF)surgery[J].Orthop Traumatol Surg Res,2016,102:67-70.
[5] LEI F,LI Z,HE W,et al.Total and hidden blood loss between open posterior lumbar interbody fusion and transforaminal lumbar interbody fusion by Wiltse approach[J].Medicine(Baltimore),2020,99(20):e19864.
[6] LEI F,LI Z,HE W,et al.Hidden blood loss and the risk factors after posterior lumbar fusion surgery:a retrospective study[J].Medicine(Baltimore),2020,99(19):e20103.
[7] XU D,CHEN X,LI Z,et al.Tranexamic acid reduce hidden blood loss in posterior lumbar interbody fusion(PLIF)surgery[J].Medicine(Baltimore),2020,99(11):e19552.
[8] 王峰,王靜成,南利平,等.氨甲環(huán)酸應(yīng)用于腰椎后路椎間融合術(shù)的安全性和有效性[J].中國(guó)脊柱脊髓雜志,2019,29(5):422-430.
[9] 班正濤,劉汝專(zhuān).腰椎椎間融合術(shù)后隱性失血的研究進(jìn)展[J].中國(guó)骨傷,2018,31(11):1077-1080.
[10] ERSKINE J G,FRASER C,SIMPSON R,et al.Blood loss with knee joint replacement[J].J R Coll Surg Edinb,1981,26(5):295-297.
[11] BAI B,TIAN Y,ZHANG Y L,et al.Prediction of hidden blood loss during posterior spinal surgery[J].Chin Med Sci J,2019,34(1):38-44.
[12] REN Z,LI S,SHENG L,et al.Topical use of tranexamic acid can effectively decrease hidden blood loss during posterior lumbar spinal fusion surgery:a retrospective study[J].Medicine(Baltimore),2017,96(42):e8233.
[13] PENG Y J,FAN Z Y,WANG Q L,et al.Comparison of the total and hidden blood loss in patients undergoing single-level open and unilateral biportal endoscopic transforaminal lumbar interbody fusion:a retrospective case control study[J].BMC Musculoskelet Disord,2023,24(1):295.
[14] 胡攀,胡月.脊柱手術(shù)圍手術(shù)期隱性失血的研究進(jìn)展[J].中醫(yī)正骨,2019,31(4):52-55.
[15] 張圣飛,張亮,張志強(qiáng),等.PLIF手術(shù)隱性失血危險(xiǎn)因素分析[J].實(shí)用骨科雜志,2018,24(8):673-676.
[16] 馬明領(lǐng),馬子健,董輝,等.改良后入路腰椎體間融合術(shù)隱性失血的影響因素分析[J].臨床醫(yī)學(xué)研究與實(shí)踐,2023,8(8):9-12.
[17] 唐安樂(lè),俞海明,陳志欽,等.腰椎退行性病斜外側(cè)椎間融合隱性失血的相關(guān)因素[J].中國(guó)矯形外科雜志,2022,30(11):979-982.
[18] WEN L,JIN D,XIE W,et al.Hidden blood loss in posterior lumbar fusion surgery:an analysis of risk factors[J].Clin Spine Surg,2018,31(4):180-184.
[19] 李蘇成,傅棟銘,李然,等.骨質(zhì)疏松癥對(duì)后入路腰椎椎體間融合術(shù)患者圍手術(shù)期隱性失血的影響[J].骨科臨床與研究雜志,2021,6(5):275-279.
[20] MIMA Y,YAGI M,SUZUKI S,et al.Hidden blood loss in extreme lateral interbody fusion for adult spinal deformity[J].J Orthop Sci,2023,28(3):509-514.
[21] ZHU L,ZHANG L,SHAN Y,et al.Analysis of hidden blood loss and its risk factors in oblique lateral interbody fusion surgery[J].Clin Spine Surg,2021,34(9):E501-E505.
[22] ABE T,MIYAZAKI M,SAKO N,et al.Efficacy of gelatin-thrombin matrix sealants for blood loss in single-level transforaminal lumbar interbody fusion[J].Medicine(Baltimore),2023,102(36):e34667.
[23] 王沛,強(qiáng)曉軍,李原,等.MIS-TLIF術(shù)的隱性失血情況及其風(fēng)險(xiǎn)因素分析[J].頸腰痛雜志,2023,44(2):162-166.
[24] GE M,ZHANG Y,YING H,et al.Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion[J].Int Orthop,2022,46(9):2063-2070.
[25] HUANG X,WANG W,CHEN G,et al.Comparison of surgical invasiveness,hidden blood loss,and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease:a retrospective cohort study[J].BMC Musculoskelet Disord,2023,24(1):274.
[26] OLMOS M,HERNANDEZ N S,KANTER M,et al.Periprocedural polypharmacy in lumbar fusions performed under spinal anesthesia compared with general anesthesia[J].Neurosurgery,2023,92(3):632-638.
[27] LI Z,LONG H,HUANG F,et al.Impact of epidural versus general anesthesia on major lumbar surgery in elderly patients[J].Clin Spine Surg,2019,32(1):E7-E12.
[28] 符碧峰,李遠(yuǎn)棟,劉愛(ài)峰,等.脊柱外科圍手術(shù)期輔助止血方法的研究進(jìn)展[J].上海醫(yī)學(xué),2023,46(1):54-59.
[29] 周慧,周立燕,王學(xué)麗,等.氨甲環(huán)酸和間斷負(fù)壓引流對(duì)腰椎術(shù)后引流量的影響[J].中國(guó)矯形外科雜志,2019,27(11):1001-1004.
[30] 趙勇,申才佳,張欣.不同術(shù)后引流方式在腰椎融合手術(shù)中的應(yīng)用比較[J].頸腰痛雜志,2019,40(2):256-257.
[31] 謝錦偉,廖刃,向兵,等.骨科加速康復(fù)圍術(shù)期患者血液管理進(jìn)展:現(xiàn)狀與未來(lái)[J].中國(guó)科學(xué):生命科學(xué),2022,52(11):1704-1714.
[32] CAO S,LV K,PENG C,et al.Efficacy and safety of erythropoietin in isolated spinal metastasis patients with total en bloc spondylectomy surgery:a case-control study[J].Eur Spine J,2023,32(3):1021-1028.
[33] 陶崑,黃哲宇,趙立明,等.氨甲環(huán)酸在股骨頸骨折全髖關(guān)節(jié)置換圍手術(shù)期的應(yīng)用[J].中華骨與關(guān)節(jié)外科雜志,2023,16(7):596-600.
[34] WANG W,DUAN K,MA M,et al.Tranexamic acid decreases visible and hidden blood loss without affecting prethrombotic state molecular markers in transforaminal thoracic interbody fusion for treatment of thoracolumbar fracture-dislocation[J].Spine(Phila Pa 1976),2018,43(13):E734-E739.
[35] HUI S,TAO L,MAHMOOD F,et al.Tranexamic acid in reducing gross hemorrhage and transfusions of spine surgeries(TARGETS):study protocol for a prospective,randomized,double-blind,non-inferiority trial[J].Trials,2019,20(1):125.
[36] 謝明華,盧政好,歐軍.氨甲環(huán)酸不同給藥途徑在單節(jié)段腰椎后路手術(shù)中的應(yīng)用觀察[J].湖北民族大學(xué)學(xué)報(bào)(醫(yī)學(xué)版),2022,39(2):45-48.
[37] 張東風(fēng),吳小東,孔清泉,等.靜脈應(yīng)用不同劑量氨甲環(huán)酸對(duì)微創(chuàng)小切口經(jīng)椎間孔腰椎椎間融合術(shù)圍術(shù)期失血量影響的前瞻性隨機(jī)對(duì)照研究[J].中國(guó)修復(fù)重建外科雜志,2022,36(4):439-445.
[38] MU X,WEI J,WANG C,et al.Intravenousadministration of tranexamic acid significantly reduces visible and hidden blood loss compared with its topical administration for dou-ble-segment posterior lumbar interbody fusion:a single-center,placebo-controlled,randomized trial[J].World Neurosurg,2019,122:e821-e827.
[39] 楊磊,饒耀劍,張昌盛,等.腰椎退變性側(cè)彎術(shù)中局部與靜脈應(yīng)用氨甲環(huán)酸[J].中國(guó)矯形外科雜志,2020,28(15):1381-1384.
[40] LUO H,SHEN C,QU T,et al.Tranexamic acid-induced focal convulsions after spinal surgery:a rare case report and literature review on side effects of accidental spinal administration of tranexamic acid[J].EFORT Open Rev,2023,8(6):482-488.
[41] 王少杰,任蘭群.隱性失血的中醫(yī)病機(jī)探討[J].環(huán)球中醫(yī)藥,2017,10(4):465-467.
[42] 張江濤,謝欣序,崔亞茹,等.中藥多糖治療化療性骨髓抑制的藥理作用研究進(jìn)展[J/OL].中華中醫(yī)藥學(xué)刊:1-18[2023-09-08]. http://kns.cnki.net/kcms/detail/21.1546.R.20230904.1508.002.html.
[43] 牛雪芳,廖奎,汪子鈴,等.當(dāng)歸多糖促進(jìn)骨髓移植小鼠造血功能重建及其機(jī)制研究[J].陸軍軍醫(yī)大學(xué)學(xué)報(bào),2022,44(16):1621-1628.
[44] BAO W,ZHANG Q,ZHENG H,et al.Radix astragali polysaccharide RAP directly protects hematopoietic stem cells from chemotherapy-induced myelosuppression by increasing FOS expression[J].Int J Biol Macromol,2021,183:1715-1722.
[45] 雷蕾,李小陽(yáng),劉駿,等.化學(xué)功效組學(xué):中藥現(xiàn)代研究的新方向——以止血藥和活血化瘀藥核心成分群研究為例[J].中國(guó)中藥雜志,2022,47(24):6803-6809.
[46] 向?yàn)槊?徐無(wú)忌.加味桃紅四物湯治療腰椎后路椎體融合術(shù)后隱性失血的臨床研究[J].云南中醫(yī)中藥雜志,2023,44(2):53-56.
[47] 班正濤,李少榮,劉汝專(zhuān),等.益血生膏方對(duì)腰椎后路椎間融合術(shù)術(shù)后隱性失血的影響[J].廣西中醫(yī)藥,2020,43(4):25-28.
[48] YOKOI H,CHAKRAVARTHY V,WINKLEMAN R,et al.Incorporation of blood and fluid management within an enhanced recovery after surgery protocol in complex spine surgery[J].Global Spine J,2022,23:21925682221120399.
[49] 鄧羅義,楊華,寧旭,等.腰椎后路手術(shù)患者隱性失血的影響因素[J].骨科臨床與研究雜志,2022,7(4):245-250.
[50] 柏天婷,冷楠楠,左瑩,等.營(yíng)養(yǎng)狀況與髖部骨折圍手術(shù)期隱性失血的研究進(jìn)展[J].聯(lián)勤軍事醫(yī)學(xué),2023,37(2):171-175.
相似文獻(xiàn)/References:
[1]徐幫杰,楊楠,白偉杰,等.坐位定點(diǎn)旋轉(zhuǎn)整復(fù)法治療腰椎間盤(pán)突出癥的療效觀察[J].中醫(yī)正骨,2015,27(11):17.
XU Bangjie,YANG Nan,BAI Weijie,et al.Observation on the curative effect of fixed-point rotational reduction in sitting position in the treatment of lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):17.
[2]白春曉,賈育松,孫旗,等.中醫(yī)藥在腰椎間盤(pán)突出癥圍手術(shù)期應(yīng)用的研究進(jìn)展[J].中醫(yī)正骨,2015,27(11):65.
[3]王少純,周英杰.郭維淮教授運(yùn)用活血益氣通經(jīng)湯治療腰椎間盤(pán)突出癥的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(11):75.
[4]鄧紅軍.硫酸鈣骨水泥椎體成形聯(lián)合后路短節(jié)段椎弓根螺釘
內(nèi)固定治療創(chuàng)傷性胸腰椎骨折[J].中醫(yī)正骨,2015,27(10):35.
[5]張莉,秦丹霞,張細(xì)姣.腹針治療椎間盤(pán)源性腰痛[J].中醫(yī)正骨,2015,27(10):38.
[6]蘇洪,張雪林.患側(cè)下肢牽引配合腰椎斜扳法治療
極外側(cè)型腰椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(10):40.
[7]吳青坡,孫國(guó)紹,王林杰.后路椎管減壓聯(lián)合腰椎椎弓根釘動(dòng)態(tài)穩(wěn)定裝置內(nèi)固定
治療單節(jié)段腰椎退行性疾病[J].中醫(yī)正骨,2015,27(10):42.
[8]謝冬群,黃中梁,葉金麗.加強(qiáng)隔附子餅灸治療腎陽(yáng)虛型腰椎間盤(pán)突出癥的
臨床研究[J].中醫(yī)正骨,2015,27(09):18.
XIE Dongqun,HUANG Zhongliang,YE Jinli.Clinical study on intensive aconite root cake separated moxibustion in the treatment of kidney-yang-deficiency-type lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):18.
[9]沈海良,錢(qián)萬(wàn)鋒,周驍棟.針刀松解聯(lián)合局部封閉與口服中藥治療腰椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(09):46.
[10]王仁燦,黃炎洪,潘偉江,等.45°肩踝懸吊牽引下撞擊腰椎療法治療L5S1椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(08):51.
[11]王碩凡,陳哲,陳巖松.腰椎融合術(shù)后假關(guān)節(jié)形成的研究進(jìn)展[J].中醫(yī)正骨,2017,29(07):51.
[12]郭營(yíng),梅偉.腰椎融合術(shù)后下肢疼痛的原因分析及治療[J].中醫(yī)正骨,2018,30(05):68.
[13]陳雙,吳奐汐,王楠,等.腰椎后路融合術(shù)后融合器沉降危險(xiǎn)因素的Meta分析[J].中醫(yī)正骨,2022,34(10):44.
CHEN Shuang,WU Huanxi,WANG Nan,et al.A Meta-analysis of risk factors associated with cage subsidence after posterior lumbar interbody fusion[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(12):44.
[14]申素昊,孔鵬,汲長(zhǎng)蛟,等.腰椎融合術(shù)后終板囊性變的研究進(jìn)展[J].中醫(yī)正骨,2024,36(01):53.